04:14:33 Europe / Stockholm

Svenska | English

Photocure

Kalender

2023-11-08	Kvartalsrapport 2023-Q3
2023-08-09	Kvartalsrapport 2023-Q2
2023-05-10	Kvartalsrapport 2023-Q1
2023-05-04	Ordinarie utdelning PHO 0.00 NOK
2023-05-03	Årsstämma 2023
2023-02-24	Bokslutskommuniké 2022
2023-02-23	Bokslutskommuniké 2022
2022-11-02	Kvartalsrapport 2022-Q3
2022-08-10	Kvartalsrapport 2022-Q2
2022-05-11	Kvartalsrapport 2022-Q1
2022-04-29	Ordinarie utdelning PHO 0.00 NOK
2022-04-28	Årsstämma 2022
2022-02-23	Bokslutskommuniké 2021
2021-11-17	Kvartalsrapport 2021-Q3
2021-08-11	Kvartalsrapport 2021-Q2
2021-07-28	Extra Bolagsstämma 2021
2021-05-21	Ordinarie utdelning PHO 0.00 NOK
2021-05-20	Årsstämma 2021
2021-05-19	Kvartalsrapport 2021-Q1
2021-03-03	Bokslutskommuniké 2020
2020-11-10	Kvartalsrapport 2020-Q3
2020-08-18	Kvartalsrapport 2020-Q2
2020-06-11	Ordinarie utdelning PHO 0.00 NOK
2020-06-10	Årsstämma 2020
2020-05-07	Kvartalsrapport 2020-Q1
2020-02-27	Bokslutskommuniké 2019
2019-11-07	Kvartalsrapport 2019-Q3
2019-08-07	Kvartalsrapport 2019-Q2
2019-06-19	Extra Bolagsstämma 2019
2019-05-14	Kvartalsrapport 2019-Q1
2019-05-10	Ordinarie utdelning PHO 0.00 NOK
2019-05-09	Årsstämma 2019
2019-02-27	Bokslutskommuniké 2018
2018-11-08	Kvartalsrapport 2018-Q3
2018-08-08	Kvartalsrapport 2018-Q2
2018-05-23	Kvartalsrapport 2018-Q1
2018-05-11	Ordinarie utdelning PHO 0.00 NOK
2018-05-09	Årsstämma 2018
2018-02-27	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-23	Kvartalsrapport 2017-Q2
2017-05-23	Kvartalsrapport 2017-Q1
2017-04-28	Ordinarie utdelning PHO 0.00 NOK
2017-04-27	Årsstämma 2017
2017-02-15	Bokslutskommuniké 2016
2016-11-15	Kvartalsrapport 2016-Q3
2016-08-23	Kvartalsrapport 2016-Q2
2016-05-10	Kvartalsrapport 2016-Q1
2016-04-29	Ordinarie utdelning PHO 0.00 NOK
2016-04-28	Årsstämma 2016
2016-02-11	Bokslutskommuniké 2015
2015-10-29	Kvartalsrapport 2015-Q3
2015-08-13	Kvartalsrapport 2015-Q2
2015-05-06	Kvartalsrapport 2015-Q1
2015-05-02	Ordinarie utdelning PHO 0.00 NOK
2015-04-30	Årsstämma 2015
2015-02-12	Bokslutskommuniké 2014
2014-11-06	Kvartalsrapport 2014-Q3
2014-08-26	Kvartalsrapport 2014-Q2
2014-05-28	Ordinarie utdelning PHO 0.00 NOK
2014-05-27	Årsstämma 2014
2014-05-07	Kvartalsrapport 2014-Q1
2014-02-27	Bokslutskommuniké 2013
2013-10-23	Kvartalsrapport 2013-Q3
2013-08-22	Kvartalsrapport 2013-Q2
2013-05-23	Ordinarie utdelning
2013-05-22	Årsstämma 2013
2013-04-25	Kvartalsrapport 2013-Q1
2013-02-28	Bokslutskommuniké 2012
2012-10-26	Kvartalsrapport 2012-Q3
2012-08-24	Kvartalsrapport 2012-Q2
2012-05-10	Årsstämma 2012
2012-04-26	Kvartalsrapport 2012-Q1
2012-02-16	Bokslutskommuniké 2011
2011-10-26	Kvartalsrapport 2011-Q3
2011-08-18	Kvartalsrapport 2011-Q2
2011-04-27	Kvartalsrapport 2011-Q1
2011-04-27	Årsstämma 2011
2011-02-17	Bokslutskommuniké 2010
2010-10-27	Kvartalsrapport 2010-Q3
2010-08-19	Kvartalsrapport 2010-Q2
2010-04-28	Kvartalsrapport 2010-Q1
2010-02-19	Bokslutskommuniké 2009
2009-11-26	Bonusutdelning

Beskrivning

Land	Norge
Lista	OB Match
Sektor	Hälsovård
Industri	Medicinteknik

Photocure är verksamma inom medicinteknik. Bolaget specialiserar sig inom lösningar för fotodynamisk teknik. Idag används lösningarna för behandling av sjukdomar som föranlett cancer i urinblåsan och HPV. Huvudmarknaderna återfinns inom dermatologi och onkologi, där produkterna används av sjukhus och forskningsinstitut på global nivå. Bolaget grundades 1993 och har huvudkontor i Oslo, Norge.

Filter

År

Typ

Språk

Rensa

2023-12-01 07:30:08 SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy +6,95% | 4,21 MNOK

2023-12-01 07:30:00 Photocure: SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy +6,95% | 4,21 MNOK

2023-11-29 10:06:00 PHO: Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China +2,86% | 16,4 MNOK

2023-11-29 10:05:43 Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China +2,86% | 16,4 MNOK

2023-11-20 17:50:30 PHO: Photocure to present at four investor conferences in November/December 2023 -5,05% | 5,27 MNOK

2023-11-20 17:50:21 Photocure to present at four investor conferences in November/December 2023 -5,05% | 5,27 MNOK

2023-11-08 08:00:15 Photocure ASA: Results for the third quarter of 2023 +0,73% | 8,96 MNOK

2023-11-08 08:00:00 Photocure ASA: Results for the third quarter of 2023 +0,73% | 8,96 MNOK

2023-11-01 08:22:08 Photocure ASA: Invitation to presentation of third quarter 2023 financial results -3,12% | 3,30 MNOK

2023-11-01 08:21:54 Photocure ASA: Invitation to presentation of third quarter 2023 financial results -3,12% | 3,30 MNOK

2023-10-12 10:32:49 PHO: Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress +6,38% | 35,0 MNOK

2023-10-12 10:32:42 Photocure: Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress +6,38% | 35,0 MNOK

2023-10-07 08:00:00 Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting +2,07% | 7,52 MNOK

2023-10-06 15:07:12 PHO: New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines +0,76% | 5,33 MNOK

2023-10-06 15:07:04 Photocure: New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines +0,76% | 5,33 MNOK

2023-10-02 13:29:23 PHO: Major shareholder disclosure in Photocure ASA -0,93% | 5,90 MNOK

2023-09-27 18:06:02 Photocure ASA: Change of Board Composition +0,38% | 6,51 MNOK

2023-09-27 18:05:59 Photocure ASA: Change of Board Composition +0,38% | 6,51 MNOK

2023-09-25 13:59:22 PHO: Major shareholder disclosure in Photocure ASA +3,52% | 12,8 MNOK

2023-09-20 12:17:48 PHO: Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint +44,08% | 89,6 MNOK

2023-09-20 12:17:36 Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint +44,08% | 89,6 MNOK

2023-08-30 16:06:45 Photocure ASA: Notification of primary insider transaction +0,69% | 9,01 MNOK

2023-08-30 16:06:36 Photocure ASA: Notification of primary insider transaction +0,69% | 9,01 MNOK

2023-08-11 11:05:42 PHO: Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint +2,93% | 18,6 MNOK

2023-08-11 11:05:34 Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint +2,93% | 18,6 MNOK

2023-08-09 08:00:22 Photocure ASA: Results for the second quarter and first half of 2023 -2,53% | 20,5 MNOK

2023-08-09 08:00:00 Photocure ASA: Results for the second quarter and first half of 2023 -2,53% | 20,5 MNOK

2023-08-08 14:26:42 PHO: Major shareholder disclosure in Photocure ASA -2,36% | 2,27 MNOK

2023-08-03 08:13:18 Photocure ASA: Invitation to presentation of second quarter and first half year 2023 financial results -2,90% | 2,09 MNOK

2023-08-03 08:13:05 Photocure ASA: Invitation to presentation of second quarter and first half year 2023 financial results -2,90% | 2,09 MNOK

2023-07-06 10:40:04 PHO: Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China +1,56% | 3,57 MNOK

2023-07-06 10:39:55 Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China +1,56% | 3,57 MNOK

2023-06-01 14:36:41 PHO: Major shareholder disclosure +0,20% | 1,32 MNOK

2023-05-24 08:32:02 Photocure ASA - Share option grant -1,89% | 3,21 MNOK

2023-05-24 08:31:46 Photocure ASA - Share option grant -1,89% | 3,21 MNOK

2023-05-10 08:00:21 Photocure ASA: Results for the first quarter of 2023 -5,23% | 15,6 MNOK

2023-05-10 08:00:00 Photocure ASA: Results for the first quarter of 2023 -5,23% | 15,6 MNOK

2023-05-04 13:22:14 Photocure ASA - Correction: Annual general meeting held +0,19% | 0,86 MNOK

2023-05-04 13:22:03 Photocure ASA - Correction: Annual general meeting held +0,19% | 0,86 MNOK

2023-05-03 18:41:34 Photocure ASA - Annual general meeting held +0,19% | 0,86 MNOK

2023-05-03 18:41:20 Photocure ASA - Annual general meeting held +0,19% | 0,86 MNOK

2023-05-03 11:38:57 Photocure ASA: Invitation to presentation of first quarter 2023 financial results -1,85% | 1,54 MNOK

2023-05-03 11:38:53 Photocure ASA: Invitation to presentation of first quarter 2023 financial results -1,85% | 1,54 MNOK

2023-05-02 17:00:45 Photocure: Nordic registry clinical data and multiple scientific programs at AUA 2023 Congress reinforce the benefits of Blue Light Cystoscopy -1,85% | 1,54 MNOK

2023-04-12 16:01:35 Photocure ASA: Annual Report 2022 -2,19% | 2,25 MNOK

2023-04-12 16:01:19 Photocure ASA - Notice of the Annual General Meeting 3 May 2023 -2,19% | 2,25 MNOK

2023-04-12 16:01:00 Photocure ASA: Annual Report 2022 -2,19% | 2,25 MNOK

2023-04-12 16:01:00 Photocure ASA - Notice of the Annual General Meeting 3 May 2023 -2,19% | 2,25 MNOK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Photocure

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden